BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 17295349)

  • 1. Midtrimester maternal serum inhibin A levels after multifetal pregnancy reduction.
    Chen HJ; Huang LW; Lin YH; Seow KM; Hsieh BC; Hwang JL; Tzeng CR
    Prenat Diagn; 2007 May; 27(5):431-4. PubMed ID: 17295349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome.
    Watt HC; Wald NJ; George L
    Prenat Diagn; 1996 Oct; 16(10):927-9. PubMed ID: 8938062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
    Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
    Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal course and outcome of twins from reduced multifetal pregnancy versus non-reduced twins.
    Nevo O; Avisar E; Tamir A; Coffler MS; Sujov P; Makhoul IR
    Isr Med Assoc J; 2003 Apr; 5(4):245-8. PubMed ID: 14509127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies.
    Räty R; Virtanen A; Koskinen P; Laitinen P; Forsström J; Salonen R; Mörsky P; Ekblad U
    Prenat Diagn; 2000 Mar; 20(3):221-3. PubMed ID: 10719325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of selective multifetal pregnancy reduction in second trimester].
    Wang XT; Li HY; Feng H; Zuo CT; Chen YQ; Li L; Wu ML
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):152-6. PubMed ID: 17537297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies.
    Garchet-Beaudron A; Dreux S; Leporrier N; Oury JF; Muller F; ;
    Prenat Diagn; 2008 Dec; 28(12):1105-9. PubMed ID: 19003979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fetal gender on second-trimester maternal serum inhibin-A concentration.
    Lam YH; Tang MH
    Prenat Diagn; 2001 Aug; 21(8):662-4. PubMed ID: 11536266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester fetal reduction to a singleton infant or twins: outcome in relation to the final number and karyotyping before reduction by transabdominal chorionic villus sampling.
    Brambati B; Tului L; Camurri L; Guercilena S
    Am J Obstet Gynecol; 2004 Dec; 191(6):2035-40. PubMed ID: 15592288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies.
    Bersinger NA; Noble P; Nicolaides KH
    Prenat Diagn; 2003 Feb; 23(2):157-62. PubMed ID: 12575025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum inhibin levels in twin and singleton pregnancies conceived by assisted reproduction.
    Maymon R; Cuckle H; Herman A
    Hum Reprod; 2006 May; 21(5):1305-8. PubMed ID: 16501040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoactive inhibin levels in early pregnancy after in vitro fertilization and embryo transfer.
    Yohkaichiya T; Polson DW; Hughes EG; MacLachlan V; Robertson DM; Healy DL; de Kretser DM
    Fertil Steril; 1993 May; 59(5):1081-9. PubMed ID: 8486178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome after multifetal pregnancy reduction.
    Antsaklis A; Souka AP; Daskalakis G; Papantoniou N; Koutra P; Kavalakis Y; Mesogitis S
    J Matern Fetal Neonatal Med; 2004 Jul; 16(1):27-31. PubMed ID: 15370079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
    Spencer K; Cowans NJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal thyroid function in multifetal pregnancies before and after fetal reduction.
    Ogueh O; Hawkins AP; Abbas A; Carter GD; Nicolaides KH; Johnson MR
    J Endocrinol; 2000 Jan; 164(1):7-11. PubMed ID: 10607932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy complications and neonatal outcomes in multifetal pregnancies reduced to twins compared with nonreduced twin pregnancies.
    Selam B; Lembet A; Stone J; Lapinski R; Berkowitz RL
    Am J Perinatol; 1999; 16(2):65-71. PubMed ID: 10355912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies. Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM; Mantingh A; Pratt JJ
    Obstet Gynecol; 1994 May; 83(5 Pt 1):661-4. PubMed ID: 8164921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception.
    Tul N; Novak-Antolic Z
    Prenat Diagn; 2006 Dec; 26(13):1206-11. PubMed ID: 17075793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-antithrombin complex and alpha-plasmin inhibitor-plasmin complex levels in singleton and twin pregnancies.
    Hayashi M; Fukasawa I; Inaba N
    Int J Clin Pract; 2006 Oct; 60(10):1244-9. PubMed ID: 16669831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal reduction from twins to a singleton: a reasonable consideration?
    Evans MI; Kaufman MI; Urban AJ; Britt DW; Fletcher JC
    Obstet Gynecol; 2004 Jul; 104(1):102-9. PubMed ID: 15229007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.